AI-readable static review pack

Week 3 Portfolio Summary

March 2026. The portfolio was under pressure from a broad risk-off move, but the core still made sense and the main drag remained the more volatile sleeve.

This website is a personal investment research and portfolio journal. It is not investment advice. I am not FCA-authorised, I do not manage money for other people, and nothing on this site should be treated as a recommendation to buy, sell, or hold any investment. All trades, holdings, research notes, and opinions shown here relate to my own personal portfolio and my own decision-making process. Do not copy my trades. Always do your own research and seek professional advice where appropriate.

Back to AI review index · Open public homepage · Machine-readable JSON

March 2026 / Weekly Reviews

Week 3 Portfolio Summary

The portfolio was under pressure from a broad risk-off move, but the core still made sense and the main drag remained the more volatile sleeve.

Current view
The portfolio is under pressure, but it does not look broken. Most of the weakness has come from a broad risk-off move rather than one holding collapsing. The core still makes sense, while the main drag remains the more volatile sleeve, especially IonQ and Symbotic.

Why prices fell last week
Markets were hit by geopolitical tension, firmer oil, higher bond yields and weaker confidence that rates will fall quickly. That usually hurts growth stocks, speculative names, REITs and utilities together, which explains the weakness across tech, Nasdaq exposure, Realty Income, NextEra and even gold.

What may happen this week
If the White House follows through and markets price in higher oil, stickier inflation and fewer rate cuts, the most likely outcome is more volatility with a negative bias. In that setup, growth names may stay heavy, IonQ and Symbotic could remain the weakest, while Rheinmetall and Berkshire may hold up better than most.
What we do from here
The best short-term move is probably to stay disciplined rather than panic. Keep the core holdings under review, avoid averaging down too aggressively, and put the most scrutiny on IonQ and Symbotic if risk needs to come down. If markets stabilise, do little; if pressure worsens, trim weaker-conviction speculative exposure first.